-
Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients
Market news
prnasiaFebruary 15, 2022
Ascletis Pharma Inc. (HKEX: 1672) today announces that Shanghai Public Health Clinical Center initiated functional cure study of anti-PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide...
-
Singapore Health Sciences Authority Issues Interim Authorization for Novavax COVID-19 Vaccine
Market news
prnasiaFebruary 15, 2022
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Singapore Health Sciences Authority...
-
G-NiiB probiotics - world's first microbiome-based immunity formulas now available at IMI
Market news
prnasiaFebruary 15, 2022
IMI - Integrated Medicine Institute, Asia's largest natural health clinic, is pleased to announce the availability of G-NiiB Immunity Pro and G-NiiB Immunity Plus probiotic formulas designed to tackle gut bacterial imbalances...
-
Largest Hospital in Queensland, Australia Acquires Multiple Accuray Radixact® Systems with the ClearRT™ Helical Fan-Beam kVCT Imaging and Synchrony® Technologies
Market news
prnasiaFebruary 15, 2022
Accuray Incorporated (NASDAQ: ARAY) announced today that Royal Brisbane and Women's Hospital (RBWH), the largest medical facility in Queensland, Australia...
-
Recbio Provides Updates on First Lyophilized mRNA Vaccine and Pre-clinical Data Showing Long-term stability and Strong immunogenicity against SARS-CoV-2
Market news
prnasiaFebruary 15, 2022
Jiangsu Recbio Technology Co., Ltd. (Recbio), a China-based company focused on the development of innovative vaccines for major diseases, announced preclinical data...
-
FDA grants EUA to Lilly’s bebtelovimab for Covid-19 treatment
Market news
Pharmaceutical-TechnologyFebruary 15, 2022
Bebtelovimab is indicated for treating mild-to-moderate Covid-19 in adults and paediatric patients aged 12 years and above.
-
Pfizer and BioNTech to extend rolling submission for Covid-19 vaccine
Market news
Pharmaceutical-TechnologyFebruary 15, 2022
Pfizer and BioNTech are set to extend their rolling submission to the US Food and Drug Administration (FDA) for amending the emergency use authorization (EUA) of the Covid-19 vaccine to include children aged six months to four years.
-
Legend Biotech Achieves Milestone Payments in BCMA CAR-T Collaboration with Janssen
Market news
AmericanPharmaceuticalReviewFebruary 15, 2022
Legend Biotech Corporation has achieved two milestones under its collaboration agreement with Janssen Biotech, Inc. for ciltacabtagene autoleucel (cilta-cel)...
-
CytoReason and Pfizer Extend Collaboration to Leverage Machine Learning in Drug Development
Market news
AmericanPharmaceuticalReviewFebruary 15, 2022
CytoReason announced the extension of its collaboration agreement with Pfizer.
-
WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
Market news
WorldPharmaNewsFebruary 15, 2022
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that Actemra®/RoActemra® (tocilizumab) intravenous (IV) has been granted World Health Organization (WHO) prequalification.
Ascletis Pharma Inc. (HKEX: 1672) today announces that Shanghai Public Health Clinical Center initiated functional cure study of anti-PD-L1 antibody ASC22 (Envafolimab) in combination with Chidamide...
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Singapore Health Sciences Authority...
IMI - Integrated Medicine Institute, Asia's largest natural health clinic, is pleased to announce the availability of G-NiiB Immunity Pro and G-NiiB Immunity Plus probiotic formulas designed to tackle gut bacterial imbalances...
Accuray Incorporated (NASDAQ: ARAY) announced today that Royal Brisbane and Women's Hospital (RBWH), the largest medical facility in Queensland, Australia...
Jiangsu Recbio Technology Co., Ltd. (Recbio), a China-based company focused on the development of innovative vaccines for major diseases, announced preclinical data...
Bebtelovimab is indicated for treating mild-to-moderate Covid-19 in adults and paediatric patients aged 12 years and above.
Pfizer and BioNTech are set to extend their rolling submission to the US Food and Drug Administration (FDA) for amending the emergency use authorization (EUA) of the Covid-19 vaccine to include children aged six months to four years.
Legend Biotech Corporation has achieved two milestones under its collaboration agreement with Janssen Biotech, Inc. for ciltacabtagene autoleucel (cilta-cel)...
CytoReason announced the extension of its collaboration agreement with Pfizer.
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that Actemra®/RoActemra® (tocilizumab) intravenous (IV) has been granted World Health Organization (WHO) prequalification.
Pharma Sources Insight JUNE2022
